Danda Trouve Investment Management’s AbbVie ABBV Stock Holding History

Danda Trouve Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$50K	Hold	371	–	–	0.09%	42
2022 Q2	$57K	Hold	371	–	–	0.09%	40
2022 Q1	$60K	Sell	371 -60	-14%	-$8.72K	0.08%	53
2021 Q4	$58K	Hold	431	–	–	0.07%	68
2021 Q3	$46K	Sell	431 -100	-19%	-$11.4K	0.06%	72
2021 Q2	$60K	Buy	531 +100	+23%	+$11.3K	0.07%	56
2021 Q1	$47K	Sell	431 -75	-15%	-$8.02K	0.06%	61
2020 Q4	$54K	Buy	506 +75	+17%	+$7.21K	0.07%	64
2020 Q3	$38K	Hold	431	–	–	0.05%	67
2020 Q2	$42K	Hold	431	–	–	0.06%	54
2020 Q1	$33K	Hold	431	–	–	0.07%	59
2019 Q4	$38K	Buy	+431	New	+$35.8K	0.05%	68

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Danda Trouve Investment Management's ABBV Position: Q3 2022 in Review

Danda Trouve Investment Management held its AbbVie (ABBV) position steady in Q3 2022 at 371 shares worth $50K. The position accounts for 0.09% of the portfolio, ranked #42.

Danda Trouve Investment Management first reported a position in ABBV in Q4 2019 and has held it in 12 quarters since. The position peaked at $60K in Q1 2022. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

Danda Trouve Investment Management held 371 shares of AbbVie worth $50K as of Q3 2022.
Danda Trouve Investment Management left its AbbVie share count unchanged in Q3 2022.
AbbVie made up 0.09% of Danda Trouve Investment Management's portfolio in Q3 2022, its #42 holding.
Danda Trouve Investment Management first reported a position in AbbVie in Q4 2019 and has held it in 12 quarters since.
Danda Trouve Investment Management's AbbVie position peaked at $60K in Q1 2022.
2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Danda Trouve Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.